Annual report
366A.TEDINET S100W8AL
Period2024-04-01 → 2025-03-31
Filed2025-06-27
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 88
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥14.1bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥13.3bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥10.7bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥9.3bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥8.3bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.1bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | ¥967m | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥1.1bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥955m | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥812m | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥657m | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥542m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.1bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥956m | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥776m | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥680m | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥560m | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥443m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥371m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥5.2bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥4.6bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥3.9bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.2bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.0bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.7bn | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥1.7bn | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥3.5bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥2.9bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥2.4bn | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥1.9bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.6bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.8bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.6bn | at 2024-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥2.8bn | at 2025-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2024-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2023-03-31d | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2022-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.1bn | at 2021-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥1.7bn | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥555m | 2023-04-01 → 2024-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥953m | 2022-04-01 → 2023-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥408m | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥684m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥269m | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥426m | 2023-04-01 → 2024-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥405m | 2022-04-01 → 2023-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥155m | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥171m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥213m | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥179m | 2023-04-01 → 2024-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥148m | 2022-04-01 → 2023-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥119m | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥152m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥142.47 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥124.88 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥102.83 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥81.3 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥13,625.02 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥42.75 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥37.47 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥30.86 | 2022-04-01 → 2023-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥24.4 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥9,600 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥633.54 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥528.54 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥434.52 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥356.08 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥59,046.35 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 66.6% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.2% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.5% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.5% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.2% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 24.5% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 25.9% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 26.0% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 25.0% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 24.8% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 5,448,200 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,448,200 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,448,200 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,448,200 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 27,241 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 122 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 108 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 103 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 90 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 91 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 21
| Segment | Item | Period | Value |
|---|---|---|---|
| Health Management Cloud Businessreportable segment | employees | at 2025-03-31 | 20 pure |
| Health Management Cloud Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥1.2bn |
| Health Management Cloud Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥1.2bn |
| Health Management Cloud Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥722m |
| Medical Checkup Solution Businessreportable segment | employees | at 2025-03-31 | 51 pure |
| Medical Checkup Solution Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥12.5bn |
| Medical Checkup Solution Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥12.5bn |
| Medical Checkup Solution Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥293m |
| Medical Institution Support Businessreportable segment | employees | at 2025-03-31 | 0 pure |
| Medical Institution Support Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥286m |
| Medical Institution Support Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥286m |
| Medical Institution Support Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥95m |
| Health Management Cloud Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥1.1bn |
| Health Management Cloud Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥1.1bn |
| Health Management Cloud Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥594m |
| Medical Checkup Solution Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥11.9bn |
| Medical Checkup Solution Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥11.9bn |
| Medical Checkup Solution Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥276m |
| Medical Institution Support Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥303m |
| Medical Institution Support Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥303m |
| Medical Institution Support Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥97m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 780
| Item | Context | Value | Unit |
|---|---|---|---|
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of reporting company (text) | FilingDateInstant | Text · Plus | |
| Company history (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Overview of affiliated entities (text) | FilingDateInstant | Text · Plus | |
| Information about employees (text) | FilingDateInstant | Text · Plus | |
| Business policy business environment issues to address etc (text) | FilingDateInstant | Text · Plus | |
| Disclosure of sustainability related financial information (text) | FilingDateInstant | Text · Plus | |
| Governance (text) | FilingDateInstant | Text · Plus | |
| Risk management (text) | FilingDateInstant | Text · Plus | |
| Strategy (text) | FilingDateInstant | Text · Plus | |
| Policy on development of human resources and internal environment strategy (text) | FilingDateInstant | Text · Plus | |
| Metrics and targets (text) | FilingDateInstant | Text · Plus | |
| Description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics metrics and targets (text) | FilingDateInstant | Text · Plus | |
| Metrics description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row1Member | Original text (Japanese)管理職に占める女性労働者の割合 | |
| Metrics description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row2Member | Original text (Japanese)労働者の男女の賃金の差異 | |
| Metrics description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row3Member | Original text (Japanese)健康診断の受診率 | |
| Metrics unit description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row3Member | ％ | |
| Metrics description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row4Member | Original text (Japanese)有給休暇取得率 | |
| Metrics unit description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row4Member | ％ | |
| Reference to other information metrics and targets | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts (text) | FilingDateInstant | Text · Plus | |
| Research and development activities (text) | FilingDateInstant | Text · Plus | |
| Overview of capital expenditures etc (text) | FilingDateInstant | Text · Plus | |
| Major facilities (text) | FilingDateInstant | Text · Plus | |
| Planned additions retirements etc of facilities (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所グロース市場 | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)完全議決権株式であり、権利内容に何ら限定のない当社における標準となる株式であります。単元株式数は100株であります。 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Description of rights plan (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Shareholding by shareholder category (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Name major shareholders | CurrentYearInstant_No1MajorShareholdersMember | Original text (Japanese)SOMPOホールディングス㈱ | |
| Address major shareholders | CurrentYearInstant_No1MajorShareholdersMember | Original text (Japanese)東京都新宿区西新宿一丁目26番１号 | |
| Name major shareholders | CurrentYearInstant_No2MajorShareholdersMember | LHP Holdings,L.P. | |
| Address major shareholders | CurrentYearInstant_No2MajorShareholdersMember | Text · Plus | |
| Name major shareholders | CurrentYearInstant_No3MajorShareholdersMember | Original text (Japanese)㈱アドバンテッジ リスク マネジメント | |
| Address major shareholders | CurrentYearInstant_No3MajorShareholdersMember | Original text (Japanese)東京都目黒区上目黒二丁目１番１号 | |
| Name major shareholders | CurrentYearInstant_No4MajorShareholdersMember | Original text (Japanese)㈱ベルシステム24ホールディングス | |
| Address major shareholders | CurrentYearInstant_No4MajorShareholdersMember | Original text (Japanese)東京都港区虎ノ門四丁目１番１号 | |
| Name major shareholders | CurrentYearInstant_No5MajorShareholdersMember | Original text (Japanese)伊藤忠商事㈱ | |
| Address major shareholders | CurrentYearInstant_No5MajorShareholdersMember | Original text (Japanese)大阪市北区梅田三丁目１番３号 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 13 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |